Thus, the significance of elevated TG2 expression and its role in promoting the drug resistance and metastatic phenotype can be rapidly translated into the clinical setting for treatment of aggressive forms of cancer, including pancreatic cancer. The gene discussed is TGM2; the disease is cancer.